Argent Biopharma Limited has released a press release.
UK Capital Raising Completed
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Argent Biopharma
- Production Completed of A$1M ArtemiC Order from SPC
- US Supply and Distribution Agreement Update
- Malta cimetra production facility update
- Cimetra dose finding study approval
- Response to ASX Query Letter
Later from Argent Biopharma
- ArtemiC Long COVID Syndrome Clinical Study Commenced
- ArtemiC receives Indian importation and sales approval
- Response to ASX Query
- Sciensus Rare EU & UK Sales and Distribution Agreement
- Patent Granted for CimetrA
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma